NewKerala.com

India's New Drug Law: How Child Deaths Forced Historic Reform

The government is taking serious action after multiple child deaths from contaminated cough syrups. A new law called the Drugs, Medical Devices, and Cosmetics Act 2025 will replace the 80-year-old existing legislation. This will give the CDSCO stronger powers to regulate drug manufacturing and distribution. The move comes after WHO issued health warnings about specific cough syrups linked to tragedies.

Key Points: Centre Proposes New Drug Law After MP Cough Syrup Tragedy

  • New law grants statutory powers to CDSCO for drug regulation
  • Bill replaces outdated 1940 Drugs and Cosmetics Act
  • Licensing process to be fully digitized for transparency
  • Enhanced coordination between state regulators and laboratories
2 min read

Centre to bring new drug law following Madhya Pradesh cough syrup tragedy

Government introduces Drugs Act 2025 after child deaths from contaminated cough syrups. CDSCO gets stronger powers to regulate medicines and ensure safety standards.

"The CDSCO will be empowered to take immediate action against spurious or substandard drugs - Government Sources"

By Shalini Bhardwaj, New Delhi, October 15

The Union Government has decided to strengthen the drug monitoring system in the country after the recent tragic incident of child deaths due to cough syrup reported in Madhya Pradesh.

A new law is being proposed to grant statutory powers to the Central Drugs Standard Control Organisation (CDSCO) to regulate the manufacture, distribution, and sale of drugs, medical devices, and cosmetics.

According to the sources, the proposed law, titled "Drugs, Medical Devices, and Cosmetics Act 2025," aims to ensure accountability and transparency in the entire process, from manufacturing to marketing. The bill will replace the existing 1940 Act and will be aligned with international standards.

"The CDSCO will be empowered to take immediate action against spurious or substandard drugs in the country. The licensing process will be fully digitised and better coordination between state-level regulators and enhanced capacity of laboratories," the sources said.

The government aims to bring significant improvements to the drug monitoring system, making it more stringent and accountable.

For a few years, several incidents of children dying due to contaminated cough syrups have been reported in states like Madhya Pradesh, Haryana, Jammu and Kashmir, and Tamil Nadu.

After the deaths of several deaths of children due to syrups in Madhya Pradesh WHO has issued on Monday issued a health advisory warning against the use and distribution of three cough syrups. These syrups are Coldrif, Respifresh TR, and ReLife.

- ANI

Share this article:

Reader Comments

R
Rohit P
About time we updated the 1940 Act! The current system is outdated and full of loopholes. Digitizing licensing and better coordination between states will definitely help prevent such tragedies.
D
David E
While I appreciate the government's initiative, I'm concerned about implementation. We have good laws on paper but poor enforcement. Hope this time they actually deliver on their promises.
S
Shreya B
The companies manufacturing these contaminated syrups should face criminal charges. Innocent children lost their lives because of corporate greed. Justice must be served! 😡
A
Arjun K
Good move by the government. Aligning with international standards will boost our pharmaceutical exports too. But the focus should remain on protecting Indian citizens first.
M
Meera T
I lost my nephew in the Madhya Pradesh incident. No law can bring him back, but I hope this prevents other families from experiencing such pain. Please implement this properly.

We welcome thoughtful discussions from our readers. Please keep comments respectful and on-topic.

Leave a Comment

Minimum 50 characters 0/50